About Interleukin-13 receptor subunit alpha-2
Interleukin-13 receptor subunit alpha-2 (IL13RA2) is a protein
from Homo sapiens identified by UniProt accession
Q14627, 380 residues long.
MolForge cross-references it against 0 known binders and
285 disease associations.
Target properties
| Protein name | Interleukin-13 receptor subunit alpha-2 |
| UniProt accession | Q14627 |
| Gene | IL13RA2 |
| Organism | Homo sapiens |
| Length | 380 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (285)
Diseases linked to this target (Open Targets).
- glioblastoma multiforme · score 0.34
- head and neck squamous cell carcinoma · score 0.19
- endometrial cancer · score 0.18
- breast adenocarcinoma · score 0.18
- gastric adenocarcinoma · score 0.15
- esophageal cancer · score 0.15
- neoplasm · score 0.12
- hepatocellular carcinoma · score 0.09
- papillary thyroid carcinoma · score 0.08
- melanoma · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14627-F1 | alphafold | PREDICTED | 86.16 | — |
Amino-acid sequence (380 residues)
MAFVCLAIGC LYTFLISTTF GCTSSSDTEI KVNPPQDFEI VDPGYLGYLY LQWQPPLSLD HFKECTVEYE LKYRNIGSET WKTIITKNLH YKDGFDLNKG IEAKIHTLLP WQCTNGSEVQ SSWAETTYWI SPQGIPETKV QDMDCVYYNW QYLLCSWKPG IGVLLDTNYN LFYWYEGLDH ALQCVDYIKA DGQNIGCRFP YLEASDYKDF YICVNGSSEN KPIRSSYFTF QLQNIVKPLP PVYLTFTRES SCEIKLKWSI PLGPIPARCF DYEIEIREDD TTLVTATVEN ETYTLKTTNE TRQLCFVVRS KVNIYCSDDG IWSEWSDKQC WEGEDLSKKT LLRFWLPFGF ILILVIFVTG LLLRKPNTYP KMIPEFFCDT
Explore Interleukin-13 receptor subunit alpha-2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets